首页> Clinical and translational medicine> Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaochu,Man

第一单位： Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

作者： Xiaochu,Man ^[1] ; Jie,Huang ^[1] ; Shujuan,Sun ^[1] ; Dongdong,Zhou ^[1] ; Baoxuan,Zhang ^[1] ; Shu,Fang ^[1] ; Fangchao,Zheng ^[1] ; Chao,Li ^[2] ; Xinzhao,Wang ^[2] ; Wei,Huang ^[3] ; Linlin,Wang ^[3] ; Qingqing,He ^[4] ; Hui,Fu ^[2] ; Yan,Zhang ^[5] ; Changrui,Liu ^[4] ; Lin,Dong ^[6] ; Xianguang,Zhao ^[3] ; Liang,Xu ^[7] ; Xiao,Sun ^[2] ; Bingjie,Fan ^[3] ; Lihua,Song ^[1] ; Zhengbo,Zhou ^[2] ; Jinming,Yu ^[3] ; Huihui,Li ^[1]

作者单位： Department of Breast Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ^[1] Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ^[2] Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ^[3] Department of Surgery, The 960th Hospital of the PLA Joint Logistics Support Force, Jinan, China. ^[4] Department of Medical Oncology, Qingdao Municipal Hospital (Group), Jinan, China. ^[5] Department of Surgery, Liaocheng Tumor Hospital, Liaocheng, China. ^[6] Department of Radiology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ^[7]

关键词 HER2‐positive metastatic breast cancer Olink Pyrotinib albumin‐bound paclitaxel